
Supernus Pharmaceuticals (SUPN) went public on May 1, 2012, when it opened at a split-adjusted price of $0.0002.
| DATE | OPEN | HIGH | LOW | CLOSE | VOLUME |
|---|---|---|---|---|---|
November 2026 | $27.4905 | $31.6200 | $25.9200 | $28.6100 | 63,513,773 |
October 2026 | $27.8164 | $28.7086 | $25.0697 | $27.4439 | 60,350,700 |
September 2026 | $27.1568 | $28.7474 | $26.1792 | $27.8164 | 41,823,300 |
August 2026 | $31.2769 | $31.9519 | $26.6370 | $27.1025 | 54,747,100 |
July 2026 | $32.0257 | $32.4951 | $29.9190 | $31.0441 | 33,618,600 |
June 2026 | $27.6689 | $33.2167 | $25.1472 | $31.8356 | 42,002,100 |
May 2026 | $29.0113 | $31.8123 | $27.5526 | $27.9483 | 43,907,100 |
April 2026 | $23.9057 | $30.5166 | $23.0058 | $28.5380 | 36,719,500 |
March 2026 | $25.0619 | $27.4206 | $21.4771 | $23.6497 | 81,359,800 |
February 2026 | $27.4904 | $27.9560 | $24.4800 | $25.3878 | 33,636,300 |
January 2026 | $27.8473 | $29.2207 | $24.5963 | $27.4517 | 39,314,900 |
December 2025 | $26.0473 | $29.4846 | $25.9542 | $27.8396 | 72,210,100 |
November 2025 | $23.2773 | $26.4042 | $22.8040 | $26.0706 | 37,666,300 |
October 2025 | $18.5675 | $23.7040 | $17.5053 | $22.7885 | 44,593,600 |
September 2025 | $18.9400 | $19.4753 | $17.2407 | $18.7072 | 51,242,400 |
August 2025 | $15.6734 | $19.3978 | $15.3242 | $18.8391 | 56,490,900 |
July 2025 | $11.3748 | $16.3019 | $11.2662 | $15.6734 | 75,868,400 |
June 2025 | $9.7609 | $11.8171 | $9.5437 | $11.4369 | 43,757,400 |
May 2025 | $9.0084 | $10.0705 | $8.2479 | $9.9782 | 18,512,000 |
April 2025 | $7.4254 | $9.1325 | $6.7039 | $8.9307 | 22,661,900 |
March 2025 | $7.4021 | $7.9453 | $6.9987 | $7.3944 | 29,392,000 |
February 2025 | $9.1092 | $9.2023 | $5.9124 | $7.1694 | 31,140,500 |
January 2025 | $9.8696 | $9.8696 | $8.5893 | $9.2333 | 22,927,100 |
December 2024 | $8.6204 | $9.8929 | $8.4885 | $9.6446 | 26,250,800 |
November 2024 | $7.0608 | $8.8997 | $7.0298 | $8.6979 | 25,196,100 |